More on GHRS
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $29.13 |
|
|||
| Open | $28.75 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $30.59 | ||||
| Day Low | $27.50 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 637,507 | ||||
- Why Psychedelic stocks are surging today
- Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
- Form 6-K GH Research PLC For: Jun 26
- Form 6-K GH Research PLC For: Jun 04
- GH Research publishes Phase 2a postpartum depression trial results
- GH Research Announces Publication of Phase 2a Postpartum Depression Results
- Form 6-K GH Research PLC For: May 21
- Form EFFECT GH Research PLC
- GH Research PLC (GHRS) PT Lowered to $65 at H.C. Wainwright
- Form SCHEDULE 13G/A GH Research PLC Filed by: Lynx1 Capital Management LP
Entities mentioned with GHRS
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Stifel | View Related Stories »
- Canaccord Genuity | View Related Stories »
- Show More...
